FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030415612> ?p ?o ?g. }

• W3030415612 abstract "e24065 Background: To determine factors associated with the development of post-treatment hypothyroidism (HY) in the head and neck (HN) population as well as evaluate the impact of socio-economic factors and survivorship program. Methods: We collected demographics, insurance coverage, disease staging, treatment characteristics, and details of thyroid function measurement as well as supplementation for all HN oncology patients (n = 608) who presented between January 2011 and January 2019 at Levine Cancer Institute, Charlotte, North Carolina. Insurance was categorized as Government (Medicaid or Medicare), Private, or Uninsured. Patient malignancies were grouped as oropharynx, oral cavity, larynx/hypopharynx, nasopharynx, nasal cavity/sinus, or primary salivary gland. Thyroid function was evaluated by use of laboratory thyroid stimulating hormone (TSH) values. Timing of thyroid supplementation was standardized to start of treatment. Details of thyroid hormone supplementation was collected. Data was analyzed with Chi-square and ANOVA methods, using SAS 9.4 (Cary, NC). Results: 483 patients (79%) had post treatment surveillance with TSH. The patients (n = 125, 21%) with no identifiable thyroid surveillance did not have any racial or socioeconomic disparities identified. Caucasian and African American thyroid surveillance rates were similar at 79% and 81%, respectively. There was no difference based on insurance: Government 81%, Uninsured 81%, and Private 76%. Of patients with thyroid surveillance, 203 (42%) developed post-treatment HY. The mean and median time frame until HY identification was 544 days and 450 days, respectively. A mean and median dose of thyroid hormone supplementation of 75 mcg of levothyroxine. Most patients had lower rates of thyroid dysfunction with TSH levels between 5-10. Fewer African Americans (24%) developed HY than Caucasians (47%). Patients with laryngeal cancer were at greatest risk to develop HY (57%), followed by oropharynx (40%) and oral cavity (40%). Staging did not demonstrate a significant difference between development of HY. Conclusions: This study is the largest cohort of HN patients to be evaluated for post HN treatment induced HY. Oncology team providers and primary care physicians should be aware of the significant rates of HY. In our institution we identified a consistency of care provided regardless of socioeconomic and racial factors." @default.
• W3030415612 created "2020-06-05" @default.
• W3030415612 creator A5005781944 @default.
• W3030415612 creator A5056077449 @default.
• W3030415612 creator A5058326522 @default.
• W3030415612 creator A5072699357 @default.
• W3030415612 creator A5073381303 @default.
• W3030415612 creator A5076616699 @default.
• W3030415612 creator A5082834950 @default.
• W3030415612 creator A5083676348 @default.
• W3030415612 creator A5088032720 @default.
• W3030415612 creator A5090501436 @default.
• W3030415612 date "2020-05-20" @default.
• W3030415612 modified "2023-09-27" @default.
• W3030415612 title "The impact of socioeconomic factors and survivorship on radiation induced hypothyroidism in a single institution cohort study." @default.
• W3030415612 doi "https://doi.org/10.1200/jco.2020.38.15_suppl.e24065" @default.
• W3030415612 hasPublicationYear "2020" @default.
• W3030415612 type Work @default.
• W3030415612 sameAs 3030415612 @default.
• W3030415612 citedByCount "0" @default.
• W3030415612 crossrefType "journal-article" @default.
• W3030415612 hasAuthorship W3030415612A5005781944 @default.
• W3030415612 hasAuthorship W3030415612A5056077449 @default.
• W3030415612 hasAuthorship W3030415612A5058326522 @default.
• W3030415612 hasAuthorship W3030415612A5072699357 @default.
• W3030415612 hasAuthorship W3030415612A5073381303 @default.
• W3030415612 hasAuthorship W3030415612A5076616699 @default.
• W3030415612 hasAuthorship W3030415612A5082834950 @default.
• W3030415612 hasAuthorship W3030415612A5083676348 @default.
• W3030415612 hasAuthorship W3030415612A5088032720 @default.
• W3030415612 hasAuthorship W3030415612A5090501436 @default.
• W3030415612 hasConcept C126322002 @default.
• W3030415612 hasConcept C2779761222 @default.
• W3030415612 hasConcept C2908647359 @default.
• W3030415612 hasConcept C526584372 @default.
• W3030415612 hasConcept C71924100 @default.
• W3030415612 hasConcept C72563966 @default.
• W3030415612 hasConcept C99454951 @default.
• W3030415612 hasConceptScore W3030415612C126322002 @default.
• W3030415612 hasConceptScore W3030415612C2779761222 @default.
• W3030415612 hasConceptScore W3030415612C2908647359 @default.
• W3030415612 hasConceptScore W3030415612C526584372 @default.
• W3030415612 hasConceptScore W3030415612C71924100 @default.
• W3030415612 hasConceptScore W3030415612C72563966 @default.
• W3030415612 hasConceptScore W3030415612C99454951 @default.
• W3030415612 hasLocation W30304156121 @default.
• W3030415612 hasOpenAccess W3030415612 @default.
• W3030415612 hasPrimaryLocation W30304156121 @default.
• W3030415612 hasRelatedWork W11275491 @default.
• W3030415612 hasRelatedWork W13304448 @default.
• W3030415612 hasRelatedWork W13417585 @default.
• W3030415612 hasRelatedWork W15770757 @default.
• W3030415612 hasRelatedWork W20183041 @default.
• W3030415612 hasRelatedWork W3579187 @default.
• W3030415612 hasRelatedWork W4541803 @default.
• W3030415612 hasRelatedWork W7183366 @default.
• W3030415612 hasRelatedWork W7982168 @default.
• W3030415612 hasRelatedWork W8528101 @default.
• W3030415612 isParatext "false" @default.
• W3030415612 isRetracted "false" @default.
• W3030415612 magId "3030415612" @default.
• W3030415612 workType "article" @default.